NAGE: Niagen Bioscience, Inc. Stock

SIC 2833 – Medicinal Chemicals and Botanical Products

Valuation
Market Cap ($M) 526.72
Enterprise Value ($M) 482.21
Book Value ($M) 46.09
Book Value / Share 0.59
Price / Book 11.43
NCAV ($M) 41.92
NCAV / Share 0.54
Price / NCAV 12.57

Profitability (mra)
Return on Invested Capital (ROIC) 0.18
Return on Assets (ROA) 0.16
Return on Equity (ROE) 0.30

Liquidity (mrq)
Quick Ratio 3.06
Current Ratio 3.57

Balance Sheet (mrq) ($M)
Current Assets 64.10
Assets 68.28
Liabilities 22.18
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 99.60
Operating Income 7.73
Net Income 8.55
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 12.11
Cash from Investing -0.14
Cash from Financing 5.37

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
08-21 13D/A Prime Tech Global Ltd 0.00
08-21 13D/A Pioneer Step Holdings Ltd 25.41 144.68

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-21 157,435 501,881 31.37
2025-04-17 140,334 603,689 23.25
2025-04-16 74,830 382,152 19.58

(click for more detail)

Similar Companies
MTEX – Mannatech, Incorporated MTVA – MetaVia Inc.
MYNZ – Mainz Biomed N.V. NATR – Nature's Sunshine Products, Inc.
NERV – Minerva Neurosciences, Inc.


Financial data and stock pages provided by
Fintel.io